scholarly article | Q13442814 |
P2093 | author name string | Kijlstra A | |
Zaal MJ | |||
Luyendijk L | |||
Hack CE | |||
Rothova A | |||
Klok AM | |||
P2860 | cites work | Ocular manifestations of genetic and developmental diseases. | Q33566490 |
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils | Q35815126 | ||
Molecular genetics, structure, and function of C-reactive protein | Q37225461 | ||
A review on the biological properties of C-reactive protein | Q37449779 | ||
Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). | Q37926949 | ||
Interleukin-8 in sepsis: relation to shock and inflammatory mediators | Q40147260 | ||
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein | Q40738906 | ||
Interleukin-8. A corneal factor that induces neovascularization | Q42050315 | ||
Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. | Q42773941 | ||
Long-term visual outcome and complications associated with pars planitis | Q58397008 | ||
Uveitis, perivenous sheathing and multiple sclerosis | Q67016911 | ||
Enhanced synthesis of neutrophil-activating peptide-I/interleukin-8 in active ulcerative colitis | Q67486683 | ||
Circulating ICAM-1 levels in serum of uveitis patients | Q67522798 | ||
Multiple Sclerosis, Sarcoidosis and Other Diseases in Patients with Pars Planitis1 | Q67841142 | ||
Pars planitis | Q68747762 | ||
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease | Q69741243 | ||
Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis | Q71297982 | ||
Identification, quantitation, and purification of a 36 kDa circulating protein associated with active pars planitis | Q71402202 | ||
Chemoattractant and neutrophil degranulation activities related to interleukin-8 in vitreous fluid in uveitis and vitreoretinal disorders | Q72569259 | ||
The association of HLA-DR15 and intermediate uveitis | Q73421833 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | uveitis | Q280027 |
P304 | page(s) | 871-874 | |
P577 | publication date | 1998-08-01 | |
P1433 | published in | British Journal of Ophthalmology | Q13443571 |
P1476 | title | Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis | |
P478 | volume | 82 |
Q35820405 | Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study |
Q40617558 | Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis |
Q42014761 | Capacity of ocular infiltrating T helper type 1 cells of patients with non-infectious uveitis to produce chemokines |
Q35575081 | Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? |
Q53368526 | Elevated concentration of cytokines in aqueous in post-vitrectomy eyes. |
Q73311066 | Elevated serum chemokine levels in Behçet's disease with uveitis |
Q26781909 | Immunopathogenic Background of Pars Planitis |
Q34460045 | Immunopathology of the noninfectious posterior and intermediate uveitides |
Q46900649 | Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy |
Q24619574 | Intraocular and serum cytokine profiles in patients with intermediate uveitis |
Q73311222 | Plasma and whole-blood chemokine levels in patients with Behcet's disease |
Q47597288 | Serum cytokine levels in active uveitis and remission |
Q45844050 | Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses |
Q44651656 | Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis |
Q35310626 | Soluble ICAM-1 serum levels in patients with intermediate uveitis |
Q46846450 | Stromal-derived factor-1 and inflammatory cytokines in retinal vein occlusion |
Q35591867 | Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. |
Q36790612 | The role of chemokines and their receptors in uveitis |
Search more.